Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gerber

Showing results (361-370 of 366) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 366 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2018
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixtoS Loibl, K E Weber, K M Timms, et al.
Vox Sanguinis|September 21, 2017
Vox Sanguinis International Forum on platelet cryopreservation: SummaryC S Cohn, L J Dumont, M Lozano, et al.
Vox Sanguinis|September 21, 2017
Vox Sanguinis International Forum on platelet cryopreservationC S Cohn, L J Dumont, M Lozano, et al.
American Journal of Medical Genetics. Part A|February 29, 2024
De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delayThoa Ha, Angela Morgan, Meghan N Bartos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2016
[Not Available]Thomas G Wendt, G Gademann, C Pambor, et al.
Pageof 37

Showing results (361-370 of 366) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 366 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2018
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixtoS Loibl, K E Weber, K M Timms, et al.
Vox Sanguinis|September 21, 2017
Vox Sanguinis International Forum on platelet cryopreservation: SummaryC S Cohn, L J Dumont, M Lozano, et al.
Vox Sanguinis|September 21, 2017
Vox Sanguinis International Forum on platelet cryopreservationC S Cohn, L J Dumont, M Lozano, et al.
American Journal of Medical Genetics. Part A|February 29, 2024
De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delayThoa Ha, Angela Morgan, Meghan N Bartos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2016
[Not Available]Thomas G Wendt, G Gademann, C Pambor, et al.
Pageof 37